Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?

Area of Science:

• Genetics
• Immunology
• Neurodevelopmental Disorders

Background:

• Autism spectrum disorder (ASD) involves complex gene-environment interactions.
• Gastrointestinal dysfunctions are common in ASD, suggesting potential microbial involvement.
• The CLEC7A gene encodes Dectin-1, a key fungal sensor involved in innate immunity.

Purpose of the Study:

• To investigate the influence of DNA polymorphisms in the CLEC7A gene on autism spectrum disorder.
• To explore the association between CLEC7A gene variations and ASD phenotypes, including subtypes and intellectual quotient.

Main Methods:

• A case-control study analyzed DNA from 478 ASD patients and 351 healthy controls.
• Single nucleotide polymorphisms (SNPs) rs16910631 and rs2078178 in the CLEC7A gene were genotyped.
• Statistical analyses included Chi-square, Kruskal-Wallis, and Mann-Whitney tests, with phenotype-based stratification.

Main Results:

• The CLEC7A rs2078178 G allele and GG genotype were more frequent in healthy controls than ASD patients, though not statistically significant overall.
• Stratification revealed significantly higher prevalence of the rs2078178 G allele and GG genotype in the Asperger group compared to other ASD subsets.
• Intellectual quotient (IQ) increased linearly with CLEC7A rs2078178 genotypes (AA, AG, GG) and showed a recessive effect for the GG genotype.

Conclusions:

• Genetic variations in the CLEC7A gene may act as a disease specifier in ASD.
• The findings suggest that genetic control of innate immune responses could influence the ASD phenotype.
• CLEC7A gene polymorphisms are associated with specific ASD characteristics and intellectual functioning.